In critically ill patients with septic shock, does hydrocortisone compared with placebo, reduce 90 day mortality?
No difference in mortality but significantly reduced ICU LOS, MV days, delay to resolution of shock and blood transfusions
- Population
- Sepsis
- Intervention
- Hydrocortisone 200 mg/day as a continuous infusion for 7 days
- Control
- Placebo
- Primary Outcome
- 90 day mortality